Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Active Biotech's partner Teva initiates a further clinical trial in multiple sclerosis
Teaching NeuroImages: MRI in advanced neuromyelitis optica.
Sphingosine and FTY720 are potent inhibitors of the transient receptor potential melastatin 7 (TRPM7) channels.
The synthetic cannabinoid R(+)WIN55,212-2 augments interferon-β expression via peroxisome proliferator-activated receptor-α
Cortical demyelination and diffuse white matter injury in multiple sclerosis.
Late relapse of non-seminomatous testicular cancer during treatment of multiple sclerosis with interferon β-1a: A case report.
Cytokine switch and bystander suppression of autoimmune responses to multiple antigens in experimental autoimmune encephalomyelitis by a single recombinant T-cell receptor ligand.
Involvement of AMPK, IKβα-NFκB and eNOS in the sildenafil anti-inflammatory mechanism in a demyelination model.
Small internal jugular veins with restricted outflow are associated with severe multiple sclerosis: a sonographer-blinded, case--control ultrasound study.
Healthcare resource use and relapses with fingolimod versus natalizumab for treating multiple sclerosis: a retrospective US claims database analysis.
Genmab Announces Ofatumumab Development Plans in RRMS and NMO
Therapeutic class review, Neurological - multiple sclerosis dalfampridine (Ampyra(TM))
Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis.
Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis.
The Antiaging Protein Klotho Enhances Oligodendrocyte Maturation and Myelination of the CNS.
Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey.
HL-A antigens and multiple sclerosis.
Optimizing IFN Beta - 1B Dose (Optims)
Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis.
Differential roles of microglia and monocytes in the inflamed central nervous system.
Cutting Edge: Integrin α4 Is Required for Regulatory B Cell Control of Experimental Autoimmune Encephalomyelitis.
Predictors for multiple sclerosis relapses after switching from natalizumab to fingolimod.
Daclizumab reduces CD25 levels on T cells through monocyte-mediated trogocytosis.
FDA Accepts Filing of BETACONNECT™* for Relapsing-Remitting Multiple Sclerosis Patients Taking BETASERON® (interferon beta-1b)
The short-term effect of an immunosuppressive treatment on CSF myelin basic protein in chronic progressive multiple sclerosis.

Pages